Trials / Completed
CompletedNCT00426673
An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.
A Multi-Center, Open-Label, Unilateral Interaction Study of Ucb 34714 on Stable Phenytoin Monotherapy During a 45 Day b.i.d. Administration Period in 15 Adult Subjects Suffering From Epilepsy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (planned)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this Phase I study in 15 adult subjects suffering from epilepsy and chronically treated with phenytoin monotherapy is to evaluate the effect of steady-state ucb 34714 administration on the steady-state plasma levels of phenytoin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brivaracetam (ucb34714) |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2006-06-01
- Completion
- 2006-06-01
- First posted
- 2007-01-25
- Last updated
- 2008-03-10
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00426673. Inclusion in this directory is not an endorsement.